FDMT
4D Molecular Therapeutics Inc.
$7.40
+$0.80(+12.12%)
91
Overall
--
Value
91
Tech
--
Quality
Market Cap
$312.44M
Volume
974.71K
52W Range
$2.24 - $11.77
Target Price
$28.78
Key Metrics Overview
| Market Cap | $312.44M | P/E Ratio | N/A |
| 52W High | $11.77 | 52W Low | $2.24 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -5.1% | 52W Position | 54.2% |
| Overall Score | 91 | Value Score | -- |
| Quality Score | -- | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-3.66 | EPS Next Est | $-3.73 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FDMT | $7.40 | +12.1% | 974.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get 4D Molecular Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW